CORXEL Acquires Worldwide (excluding Greater China) Rights to an Oral Small Molecule GLP-1 ...
CORXEL expands its cardiometabolic pipeline into obesity and diabetesNEW JERSEY and SHANGHAI, Dec. 23, 2024 (GLOBE NEWSWIRE) -- (CORXEL), a leading biotech company committed to bringing innovative ...